Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00467701
Status:
COMPLETED
Last Update Posted:
2009-01-19
First Post:
2007-04-30
Brief Title:
Community Acquired Pneumonia in Telemark and Ostfold
Sponsor:
Sykehuset Telemark
Organization:
Sykehuset Telemark
Study Overview
Official Title:
Prevalence of Legionella Infections Bacterial Etiology in Pneumonia Among Patients Admitted to Hospital- and Risk FactorsCharacteristics for These PatientsTranslated From Norwegian
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPITO
Brief Summary:
The aim of the study is to investigate the bacterial causes in community acquired pneumonia in adults admitted to hospital in two counties in Norway and to look at possible factors that makes the patients susceptible to pneumonia
Detailed Description:
In Norway there is little knowledge of which bacterias that causes pneumonia in patients admitted to hospital There are also few registered cases of Legionnaires disease every year compared to our neighbour countries
Therefore 500 patients with community acquired pneumonia admitted to Telemark hospital and Ostfold hospital in Norway will be tested by urin antigen test for the detection of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae We will also perform routine bacterial culture of sputum and culture on medium for isolation of Legionella species A throat swab from the patients will be tested for Mycoplasma pneumoniae Chlamydophila pneumoniae and Bordetella pertussis using PCR-techniques Legionella-serology will also be performed In addition all the included patients are invited to fill in a questionnaire in order to look for risk factors for developing community acquired pneumonia
Therefore 500 patients with community acquired pneumonia admitted to Telemark hospital and Ostfold hospital in Norway will be tested by urin antigen test for the detection of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae We will also perform routine bacterial culture of sputum and culture on medium for isolation of Legionella species A throat swab from the patients will be tested for Mycoplasma pneumoniae Chlamydophila pneumoniae and Bordetella pertussis using PCR-techniques Legionella-serology will also be performed In addition all the included patients are invited to fill in a questionnaire in order to look for risk factors for developing community acquired pneumonia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NSD 16388 | None | None | None |
| REK S-05393 | None | None | None |